Division of Critical Care and Trauma, The George Institute for Global Health, University of Sydney, Sydney, Australia,
Intensive Care Med. 2015 Sep;41(9):1611-9. doi: 10.1007/s00134-015-3878-y. Epub 2015 Jun 3.
Recent evidence indicates that the choice of intravenous fluids may affect outcomes in critically ill patients.
We recorded the administration of resuscitation fluids in patients admitted to Australian and New Zealand adult intensive care units (ICUs) for a 24-h period at 6 time points between 2007 and 2013. Changes in patterns of fluid use over this period were determined using regression analyses.
Of the 2825 patients admitted to the 61 ICUs on the 6 study days, 754 (26.7%) patients received fluid resuscitation. Of those receiving fluid resuscitation, the proportion of patients receiving crystalloid significantly increased from 28.9% (41/142) in 2007 to 50.5% (48/95) in 2013 (adjusted odds ratio (OR) 2.93; 95% confidence intervals (CI) 1.35-6.33; p = 0.006); of these, the proportion of patients receiving buffered salt solutions significantly increased from 4.9% (7/142) in 2007 to 31.6% (30/95) in 2013 (OR 7.00; 95% CI 2.14-22.92; p = 0.001). The use of colloids significantly decreased from 59.9% (85/142) in 2007 to 42.1% (40/95) in 2013 (adjusted OR 0.34; 95% CI 0.16-0.74; p = 0.007) due to a significant decrease in the proportion of patients receiving gelatin; 28.9% (41/142) to 2.1% (2/95) (OR 0.10; 95% CI 0.03-0.29; p ≤ 0.001).
Fluid resuscitation practice in Australia and New Zealand adult ICUs has changed over the 6-year study period. Crystalloid use increased primarily due to an increase in the use of buffered salt solutions while overall the use of colloid has decreased.
最近的证据表明,静脉输液的选择可能会影响危重症患者的结局。
我们记录了 2007 年至 2013 年期间的 6 天内,澳大利亚和新西兰成人重症监护病房(ICU)中 61 个 ICU 每 24 小时接受复苏液治疗的患者的输液情况。使用回归分析确定在此期间液体使用模式的变化。
在 6 个研究日入住 61 个 ICU 的 2825 名患者中,754 名(26.7%)患者接受了液体复苏。在接受液体复苏的患者中,接受晶体液的患者比例从 2007 年的 28.9%(41/142)显著增加到 2013 年的 50.5%(48/95)(调整后的优势比(OR)2.93;95%置信区间(CI)1.35-6.33;p=0.006);其中,接受缓冲盐溶液的患者比例从 2007 年的 4.9%(7/142)显著增加到 2013 年的 31.6%(30/95)(OR 7.00;95%CI 2.14-22.92;p=0.001)。胶体的使用从 2007 年的 59.9%(85/142)显著减少到 2013 年的 42.1%(40/95)(调整后的 OR 0.34;95%CI 0.16-0.74;p=0.007),主要是由于接受明胶的患者比例显著减少,从 28.9%(41/142)降至 2.1%(2/95)(OR 0.10;95%CI 0.03-0.29;p≤0.001)。
在 6 年的研究期间,澳大利亚和新西兰成人 ICU 的液体复苏实践发生了变化。晶体液的使用增加主要是由于缓冲盐溶液的使用增加,而胶体的总体使用减少。